In conclusion, we found that BRAFi-resistant melanoma adapt their mitochondrial metabolism to favorize glucose-derived glutamate synthesis, cysteine uptake trough xCT, and glutathione synthesis implicating NRF2 pathway. This evidence concerns the gene SLC7A11 and melanoma.